Cancer Family

Female Reproductive System Adnexal Neoplasm

Non-malignant765 active trials5 approved drugs94 evidence items

NCIt: C212117

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Literature

Linked publications (189)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 101–125 of 189 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Birinapant enhances cisplatin sensitivity in epithelial ovarian cancer through modulation of apoptotic and survival signaling pathways.
Elham Shahnazi, Arman Rostamlou, Aras Gezer et al. · Cancer Chemother Pharmacol · Sep 8, 2026 · PMID 42709209 · candidate dictionary pubmed
Hope is linked with more favorable tumor molecular signatures in serous ovarian cancer.
Susan K Lutgendorf, Benjamin W Corn, Premal H Thaker et al. · Brain Behav Immun · Sep 8, 2026 · PMID 42710689 · candidate dictionary pubmed
PARP16 is a Druggable Regulator of Ribosome MARylation and Protein Homeostasis in Ovarian Cancer Cells.
Sridevi Challa, Morgan Dasovich, Jonathan C Abshier et al. · J Biol Chem · Sep 8, 2026 · PMID 42710679 · candidate dictionary pubmed
Evaluation of Phytocannabinoids as Antitumor Agents against Ovarian Cancer Cells in Combination with Carboplatin.
Uri Warter, Yuval Yogev, David C Nwobodo et al. · ACS Omega · Sep 8, 2026 · PMID 42729764 · candidate dictionary pubmed
Transcriptomic analysis of a phase 1 trial for intraperitoneal monocytes plus IFNs in ovarian cancer reveals support and recruitment of cell-mediated immunity.
Franklin Ning, Emily San Andres-Montalvan, Thomas J Meyer et al. · J Immunother Cancer · Sep 7, 2026 · PMID 42705863 · candidate dictionary pubmed
SMPDM3B-loaded extracellular vesicles from tumor-associated macrophages drive ovarian cancer chemoresistance by inhibiting the cGAS/STING pathway.
Xin Liang, Hanlu Yang, Lan Hong · Arch Biochem Biophys · Sep 7, 2026 · PMID 42705430 · candidate dictionary pubmed

Correction: Ferroptosis and chemotherapy resistance in ovarian cancer: molecular mechanisms and therapeutic opportunities.

Shuqing Li, Lina Yang, Zhiling Zhu · J Ovarian Res · Sep 7, 2026 · PMID 42702713 · candidate dictionary pubmed

Patient-derived organoids as predictor of clinical response in ovarian cancer: a systematic review.

Merel Vegter, Prakriti Garkhail, Gatske M Nieuwenhuyzen-de Boer et al. · Transl Oncol · Sep 6, 2026 · PMID 42702147 · candidate dictionary pubmed

Temporal trends in short-term mortality in more than 5000 patients with early-stage ovarian cancer in Denmark and Sweden.

Ida Hustad Andresen, Guoqiao Zheng, Louise Baandrup et al. · Eur J Obstet Gynecol Reprod Biol · Sep 6, 2026 · PMID 42715677 · candidate dictionary pubmed

VEGFR2-targeted NIR-II fluorescent probe for precise imaging and surgical navigation of ovarian cancer.

Nannan Tian, Shuxian Zhao, Fan Xu et al. · Bioorg Chem · Sep 5, 2026 · PMID 42184579 · candidate dictionary pubmed

Diagnosis of ovarian cancer using multiple biomarkers of CA 125, CA153, CA 19-9, CEA, HE4 and ROMA index.

Chun-Feng Ren, Gen-Hui Ren, Li-Wei Ma et al. · Ann Biol Clin (Paris) · Sep 4, 2026 · PMID 42698297 · candidate dictionary pubmed

Flavonoids as promising natural therapeutics in ovarian cancer treatment: A comprehensive review.

Yuan Chen, Xiaohua Tang, Yurong Zou et al. · J Steroid Biochem Mol Biol · Sep 4, 2026 · PMID 42697337 · candidate dictionary pubmed

Targeted Modulation of Abundant Proteins Enhances Proteomic Profiling of Ovarian Cancer Ascites: A Pilot Technical Workflow Comparison.

Zongkai Peng, James Lausen, Doris M Benbrook et al. · J Proteome Res · Sep 4, 2026 · PMID 42695897 · candidate dictionary pubmed

Prevalence of BRCA1/2 variants in an Ovarian Cancer Cohort: outcomes from a Nationwide Testing Program.

Ciara S McNevin, Kate Murphy, Pierre Murchan et al. · Eur J Hum Genet · Sep 3, 2026 · PMID 42693191 · candidate dictionary pubmed

Redirected T-cell cytotoxicity identifies BRD9-PTGES axis as an immune-sensitising vulnerability in ovarian cancer.

Shanni Guo, Peng Shi, Changrui Yang et al. · Biochem Biophys Res Commun · Sep 3, 2026 · PMID 42349121 · candidate dictionary pubmed

Comparative efficacy and safety of traditional Chinese medicine injections combined with chemotherapy in ovarian cancer: A systematic review and network meta-analysis.

Yang Liu, Wenrui Huang, Zhongkun Guo · J Ethnopharmacol · Sep 2, 2026 · PMID 42685937 · candidate dictionary pubmed

Xanthomicrol shifts the ERα/ERβ balance and promotes a less aggressive phenotype in SKOV‑3 ovarian cancer cells.

Isis Santos, Gabriel Gutiérrez-Ospina, Adelina Jiménez-Arellanes et al. · Nat Prod Res · Sep 2, 2026 · PMID 42685347 · candidate dictionary pubmed

Investigating the phytochemical composition of Curcuma longa, Azadirachta indica, and Asparagus racemosus using network pharmacology and molecular docking approaches for ovarian cancer therapy.

Seneha Santoshi, Aastha Tanwar, Riddhi Bahri et al. · Z Naturforsch C J Biosci · Sep 2, 2026 · PMID 42677485 · candidate dictionary pubmed

VISTA+ Neutrophils Contribute to Platinum Resistance by Suppressing CD8+ T Cells in High-Grade Serous Ovarian Cancer.

Chuying Huo, Xibo Zhao, Dongdong Ye et al. · Cancer Immunol Res · Sep 2, 2026 · PMID 42390478 · candidate dictionary pubmed

PRMT5 Inhibition by SCR-6920 Downregulates HIF-1α and Exhibits Synergistic Antitumor Activity with Bevacizumab in Ovarian Cancer.

Guimei Yang, Huixia Dou, Liting Xue et al. · Mol Cancer Ther · Sep 2, 2026 · PMID 42012942 · candidate dictionary pubmed

Diagnostic significance of cancer antigen 125/carcinoembryonic antigen ratio combined with IOTA-ADNEX model in discriminating between primary ovarian cancer and ovarian metastases.

Yaoqin Wang, Qianyi Zhang, Shixin Huang et al. · Quant Imaging Med Surg · Sep 1, 2026 · PMID 42701482 · candidate dictionary pubmed

Altered ANG/TIE gene expression in advanced ovarian cancer is not accompanied by disproportionate body water accumulation relative to perioperative fluid balance.

Sarah Reifenhaeuser, Katrin Stein, Stilla Frede et al. · Sci Rep · Sep 1, 2026 · PMID 42680803 · candidate dictionary pubmed

Progesterone Is Associated With Increased Vasohibin-2 Expression, Tubulin Detyrosination, and Paclitaxel Sensitivity in PR-Negative Ovarian Cancer Cells.

Takahiro Koyanagi, Yasushi Saga, Yoshifumi Takahashi et al. · Cancer Rep (Hoboken) · Sep 1, 2026 · PMID 42702875 · candidate dictionary pubmed

A Novel BRCA1 Pathogenic Variant in Tunisian Patient With High Grade Ovarian Cancer: Favorable Therapeutic Response to Olaparib.

Nihel Ammous-Boukhris, Rania Abdelmaksoud-Dammak, Ameni Feki et al. · Cancer Rep (Hoboken) · Sep 1, 2026 · PMID 42693633 · candidate dictionary pubmed

Clinical Benefit of Pembrolizumab in Lynch Syndrome-Associated Advanced Ovarian Cancer With Germline MSH6 Variant: A Case Report.

Tomomi Yokozawa, Sayako Nakagawa, Yukio Suzuki et al. · Clin Case Rep · Sep 1, 2026 · PMID 42683025 · candidate dictionary pubmed